Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$504.27NASDAQ Previous Close - Last Trade as of 3:59PM ET 4/06/20

Today's Change+10.95(2.22%)
Bid (Size)$494.56 (1)
Ask (Size)$523.99 (1)
Day Low / High$488.89 - 511.01

View Biotechnology IndustryPeer Comparison as of 04/06/2020


Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $504.27
Change: +10.95 (2.22%)
Volume: 65.00
3:59PM ET 4/06/2020

Biogen Inc ( NASDAQ )

Price: $311.39
Change: +10.88 (3.62%)
Volume: 3.2 M
3:59PM ET 4/06/2020

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $255.30
Change: +16.99 (7.13%)
Volume: 84.00
3:59PM ET 4/06/2020

Read more news Recent News

Analyst Actions: Wells Fargo Lifts Regeneron Pharmaceuticals' Price Target to $435 From $370, Keeps Equal-Weight Rating
11:53AM ET 4/06/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) has an average analyst rating of buy, with an average price target of $459. Price: 491.36, Change: -1.96, Percent Change:...

Analysts' Scale Up Regeneron Pharmaceuticals' 2020, 2021 Earnings Estimates
8:35AM ET 4/04/2020 MT Newswires

The 2020 and 2021 full year forecasted earnings estimates for Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 493.32) have been increased. The...

Insider Trends: Insider at Regeneron Pharmaceuticals Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:54PM ET 4/03/2020 MT Newswires

On Apr 01, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 9,000 shares. A portion of these optioned shares (6,964...

S&P 500 Declines Sixth Week in Seven as Airlines, Financials Weigh
4:37PM ET 4/03/2020 MT Newswires

The Standard & Poor's 500 Index continued to be plagued by the economic fallout of COVID-19 as dismal data on the labor market coupled with increasingly...

View all Commentary and Analysis

Investing In The Healthcare Turnaround
7:27PM ET 4/06/2020 Seeking Alpha

Coronavirus Roundtable - Strains And Hopes In The Healthcare Sector
7:30AM ET 4/04/2020 Seeking Alpha

Biotech Companies In The Race To Find COVID-19 Treatment
2:13PM ET 4/03/2020 Seeking Alpha

REGN, MAR, CWH, TRWH and MANU as Zacks Bull and Bear of the Day
12:44PM ET 4/03/2020 Zacks

REGN, MAR, CWH, TRWH and MANU as Zacks Bull and Bear of the Day

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Number of Employees7,400
Recent SEC Filing04/03/20204
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Executive VP-Research & DevelopmentNeil Stahl

Company Highlights

Price Open$503.38
Previous Close$504.27
52 Week Range$271.37 - 518.00
Market Capitalization$54.5 B
Shares Outstanding108.2 M
SectorHealth Technology
Next Earnings Announcement05/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$17.75
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin26.91%
Return on Equity20.75%

Analyst Ratings as of 03/27/2020

Consensus RecommendationConsensus Icon
Powered by Factset